Utility and cost of low-vacuum reinfusion drains in patients undergoing surgery for subcapital hip fracture repair. A before and after cohort study

Vox Sanguinis

Volumn 106, Issue 1, 2014, Pages 83-91

  Munoz M ^a   Iglesias, D ^b   Garcia Erce, J A ^c   Cuenca, J ^b   Herrera, A ^c   Martin Montanez E ^a   Pavia, J ^a  

^a UNIVERSITY OF MÁLAGA   (Spain)

^b HOSPITAL UNIVERSITARIO MIGUEL SERVET   (Spain)

^c HOSPITAL SAN JORGE   (Spain)

Author keywords

Allogeneic transfusion; IV iron; Low vacuum reinfusion drain; Recombinant human erythropoietin; Subcapital hip fracture; Transfusion protocol

Indexed keywords

HEMOGLOBIN; IRON SACCHARATE; RECOMBINANT ERYTHROPOIETIN;

AGED; ANTICOAGULANT THERAPY; ARTICLE; BLEEDING; BLOOD TRANSFUSION; COHORT ANALYSIS; COMORBIDITY; CONTROLLED STUDY; COST; ERYTHROCYTE CONCENTRATE; FEMALE; HIP ARTHROPLASTY; HIP FRACTURE; HOSPITALIZATION COST; HUMAN; LOW VACUUM REINFUSION DRAIN; MAJOR CLINICAL STUDY; MALE; MEDICAL DEVICE; OPERATION DURATION; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RESPIRATORY TRACT INFECTION; SUCTION DRAINAGE; SURGICAL INFECTION; SURGICAL MORTALITY; TIME TO TREATMENT; TOTAL HIP PROSTHESIS; URINARY TRACT INFECTION; WOUND COMPLICATION;

ALLOGENEIC TRANSFUSION; IV IRON; LOW-VACUUM REINFUSION DRAIN; RECOMBINANT HUMAN ERYTHROPOIETIN; SUBCAPITAL HIP FRACTURE; TRANSFUSION PROTOCOL;

AGED; AGED, 80 AND OVER; BLOOD TRANSFUSION; COHORT STUDIES; ERYTHROPOIETIN; FEMALE; HIP FRACTURES; HUMANS; IRON; MALE; POSTOPERATIVE HEMORRHAGE; SUCTION; VACUUM;

EID: 84890790654     PISSN: 00429007     EISSN: 14230410     Source Type: Journal    
DOI: 10.1111/vox.12071     Document Type: Article

References (30)

1. WHA 63.12 (resolution). Availability, safety and quality of blood products, 21 May 2010, Geneva, Switzerland. Available at: http://apps.who.int/gb/ebwha/pdf_files/WHA63/A63_R12-en.pdf. (accessed April 16 2003)
2. Shander A, Van Aken H, Colomina MJ, et al.: Patient blood management in Europe. Br J Anaesth 2012; 109:55-68
3. García-Erce JA, Cuenca J, Solano V: Predictive factors for transfusion requirements in patients over 65 years old with subcapital hip fracture. Med Clin (Barc) 2003; 120:161-166
4. Swain DG, Nightingale PG, Patel JV: Blood transfusion requirements in femoral neck fracture. Injury 2000; 31:7-10
5. Adunsky A, Lichtenstein A, Mizrahi E, et al.: Blood transfusion requirements in elderly hip fracture patients. Arch Gerontol Geriatr 2003; 36:75-81
6. Morritt DG, Morritt AN, Kelley SP, et al.: Blood ordering protocol on proposed surgical implant in fracture neck of femur patients. Ann R Coll Surg Engl 2005; 87:445-448
7. Shokoohi A, Stanworth S, Mistry D, et al.: The risks of red cell transfusion for hip fracture surgery in the elderly. Vox Sang 2012; 103:223-230
8. García-Erce JA, Cuenca J, Muñoz M, et al.: Perioperative stimulation of erythropoiesis with intravenous iron and erythropoietin reduces transfusion requirements in patients with hip fracture. A prospective observational study. Vox Sang 2005; 89:235-243
9. García-Erce JA, Cuenca J, Haman-Alcober S, et al.: Efficacy of preoperative recombinant human erythropoietin administration for reducing transfusion requirements in patients undergoing surgery for hip fracture repair. An observational cohort study. Vox Sang 2009; 97:260-267
10. Muñoz M, García-Erce JA, Villar I, et al.: Blood conservation strategies in major orthopaedic surgery: efficacy, safety and European regulations. Vox Sang 2009; 96:1-13
11. Muñoz M, Slappendel R, Thomas D: Laboratory characteristics and clinical utility of post-operative cell salvage: washed or unwashed blood trans-fusion? Blood Transfus 2011; 9:248-261
12. Muñoz M, Kühlmorgen B, Ariza D, et al.: Which patients are more likely to benefit from postoperative shed blood salvage after unilateral total knee replacement? An analysis of 581 consecutive procedures. Vox Sang 2007; 92:136-141
13. British Committee for Standards in Haematology: Blood transfusion Task Force. Guidelines for the clinical use of red cell transfusion. Br J Haematol 2001; 113:24-32
14. Carson JL, Terrin ML, Noveck H, et al.: Liberal or restrictive transfusion in high-risk patients after hip surgery. N Engl J Med 2011; 365:2453-2462
15. Horan TC, Gaynes RP, Martone WJ, et al.: Centers of Disease Control definitions of nosocomial surgical site infections, 1992: a modification of CDC definitions of surgical wound infections. Infect Control Hosp Epidemiol 1992; 13:606-608
16. Kaplan RS, Anderson SR: Time-driven activity-based costing. Harv Bus Rev 2004; 82:131-138
17. Muñoz M, Ariza D, Campos A, et al.: The cost of post-operative shed blood salvage after total knee arthroplasty: an analysis of 1, 093 consecutive procedures. Blood Transfus 2013; 11:260-271
18. Garcia-Erce JA, Bisbe E, Alfonso E, et al.: The 'true' costs of blood: the average unit production cost of an erythrocyte concentrate in Spain from a societal perspective. Transfus Altern Transfus Med 2010; 11(Suppl. 1):16
19. RESOLUCIÓN: de 30 de julio de, de la Dirección Gerencia del Servicio Aragonés de Salud. Boletín Oficial Aragón 2012; 156:16786-16792
20. Carson JL, Altman DG, Duff A, et al.: Risk of bacterial infection associated with allogenic blood transfusion among patients undergoing hip fracture repair. Transfusion 1999; 39:694-700
21. Dobbs RE, Parvizi J, Lewallen DG: Perioperative morbidity and 30-day mortality after intertrochanteric hip fractures treated by internal fixation or arthroplasty. J Arthroplasty 2005; 20:963-966
22. Muñoz M, Leal-Noval SR: Restrictive transfusion triggers in major orthopaedic surgery: effective and safe? Blood Transfus 2013; 11:169-171
23. Muñoz M, Breymann C, García-Erce JA, et al.: Efficacy and safety of intravenous iron therapy as an alternative/adjunct to allogeneic blood transfusion. Vox Sang 2008; 94:172-183
24. Bisbe E, García-Erce JA, Díez-Lobo AI, et al.: A multicentre comparative study on the efficacy of intravenous ferric carboxymaltose and iron sucrose for correcting preoperative anaemia in patients undergoing major elective surgery. Br J Anaesth 2011; 107:477-478
25. Weber EW, Slappendel R, Hémon Y, et al.: Effects of epoetin alfa on blood transfusions and postoperative recovery in orthopaedic surgery: the European Epoetin Alfa Surgery Trial (EEST). Eur J Anaesthesiol 2005; 22:249-257
26. Muñoz M, Gómez-Ramírez S, Cuenca J, et al.: Very-short-term perioperative intravenous iron administration and postoperative outcome in major orthopedic surgery: a pooled analysis of observational data from 2547 patients. Transfusion 2013. doi: 10.1111/trf.12195. [Epub ahead of print]
27. Zufferey PJ, Miquet M, Quenet S, et al.: Tranexamic acid in hip-fracture surgery (THIF) study. Tranexamic acid in hip fracture surgery: a randomized controlled trial. Br J Anaesth 2010; 104:23-30
28. Moonen AF, Knoors NT, van Os JJ, et al.: Retransfusion of filtered shed blood in primary total hip and knee arthroplasty: a prospective randomized clinical trial. Transfusion 2007; 47:379-384
29. Slappendel R, Weber EW, Benraad B, et al.: Does ibuprofen increase perioperative blood loss during hip arthroplasty? Eur J Anaesthesiol 2002; 19:829-831
30. Fleiss JL: Determining sample sizes needed to detect a difference between two proportions; in: Fleiss JL, Lewin B, Chopaile M (eds): Statistical Methods for Rates and Proportions, 2nd edn. New York, Wiley, 1981:38-45